Tuesday, 19 Nov 2019

You are here

Shoe Inserts Disappoint with Plantar Heel Pain

A report from the British Journal of Sports Medicine shows that commonly used drug store shoe inserts or customized orthotics are often ineffective in managing plantar heel pain. (Citation source bit.ly/2puzUbm)

Reuters reports on the results of a study addressing plantar heel pain that accounts for as much as 15% of foot symptoms  and 10% of running injuries. 

A systematic review of the literature included 20 randomized controlled trials comparing foot orthoses with a control population (either no intervention, sham or other conservative treatment) in patients with plantar heel pain (PHP).

Six studies showed no difference in short-term outcomes between prefabricated orthoses and sham orthoses for pain.

No difference was found between prefabricated orthoses and custom orthoses for pain at short term.

Results suggests that orthotics might work for some people, but not others, and that time, rather than the insert, may be most important in the ultimate outcomes.

Other options for patients with PHP includes the use of night splints, stretching exercises, supervised physical therapy or modification of exercise and lifestyle.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Mallinckrodt Receives SEC Subpoena

Reuters reports that Mallinckrodt Plc has received a subpoena from the U.S. Securities and Exchange Commission for documents related to the drugmaker’s lawsuit against the U.S. Department of Health and Human Services (HHS).

ACR Responds to CY2020 Medicare Physician Fee Schedule Proposed Rule

Rheumatology leaders commend CMS for proposing E/M code changes and urge agency to make additional changes to final rule.d

Parenteral Out-Performs Oral Weekly Methotrexate

A systematic review in PLOS suggests that parenteral MTX therapy is more successful than oral MTX in achieving optimal disease activity control. 

ACR Survey Shows Half of Patients Cannot Afford Treatments

Americans living with rheumatic disease face significant healthcare challenges, according to a national patient survey released this week by the American College of Rheumatology. More than 1,500 U.S. adults living with rheumatic disease responded to the survey, which asked a range of questions related to healthcare access, affordability and lifestyle. Key findings include that even though 90 percent of respondents reported having health insurance coverage, nearly 60 percent said they had difficulty affording their medications or treatments in the past year.

Medical Use of Cannabis in 2019

JAMA has published an overview of cannabis and its medical uses. Although nearly 10% of cannabis users in the United States report using it for medicinal purposes, there is insufficient evidence to support the use of medical cannabis for most conditions for which its use is advocated or advised. Nevertheless, there is increase in favoring the public availability of cannabis, largely for the management of more than 50 medical conditions.